We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

16 hedge funds and large institutions have $40.9M invested in VIVEVE MED INC in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

261% more capital invested

Capital invested by funds: $11.3M → $40.9M (+$29.6M)

100% more funds holding

Funds holding: 8 → 16 (+8)

Holders
16
Holders Change
+8
Holders Change %
+100%
% of All Funds
0.43%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
9
Increased
5
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$17.3M
2
HighTower Advisors
HighTower Advisors
Illinois
+$1.73M
3
CAD
Craig A. Drill
+$312K
4
Goldman Sachs
Goldman Sachs
New York
+$252K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$232K

Top Sellers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
-$372K

VIVE Hedge Fund Activity: Q3 2016 in Review

16 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q3 2016, worth a combined $40.9M — up 261% from $11.3M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VIVE positions and 0 closed out — a net gain of 9 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $17.3M. The largest seller was Pura Vida Investments, cutting an estimated $372K.

  • 16 institutional investors held VIVEVE MED INC (VIVE) as of Q3 2016, up from 8 in Q2 2016.
  • Funds reported $40.9M of VIVEVE MED INC stock for Q3 2016, up 261% quarter-over-quarter.
  • 9 funds opened new VIVEVE MED INC positions in Q3 2016 and 0 closed out, a net change of +9 holders.
  • The largest VIVEVE MED INC buyer in Q3 2016 was Stonepine Capital Management, an estimated $17.3M added.
  • The largest VIVEVE MED INC seller in Q3 2016 was Pura Vida Investments, an estimated $372K sold.

Based on aggregated 13F filings for Q3 2016.